TY - JOUR
T1 - Diterpene glycosides from Holothuria scabra exert the α-synuclein degradation and neuroprotection against α-synuclein-Mediated neurodegeneration in C. elegans model
AU - Chalorak, Pawanrat
AU - Sornkaew, Nilubon
AU - Manohong, Preeyanuch
AU - Niamnont, Nakorn
AU - Malaiwong, Nawaphat
AU - Limboonreung, Tanapol
AU - Sobhon, Prasert
AU - Aschner, Michael
AU - Meemon, Krai
N1 - Funding Information:
This study was supported by the Royal Golden Jubilee Ph.D. scholarship ( PHD/0137/2559 ) to PC and Mahidol University (Basic Research Fund: fiscal year 2021 – BRF2-NDFR27/2564 ) to KM. The study was also partially supported by a CIF grant, Faculty of Science, Mahidol University. H. scabra sea cucumbers were kindly provided by Coastal Fisheries Research and Development Center, Prachuap Khiri Khan province, Thailand. C. elegans strains used in this study were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs ( P40 OD010440 ). We thank the Analytical Imaging Facility (AIF) at Albert Einstein College of Medicine, which is sponsored by NCI cancer center support grant [ P30CA013330 ] and Shared Instrumentation Grant (SIG) [ 1S10OD023591-01 ]. MA was supported in part by grants from the National Institute of Environmental Health Sciences R01ES10563 and R01ES07331 .
Publisher Copyright:
© 2021 Elsevier B.V.
PY - 2021/10/28
Y1 - 2021/10/28
N2 - Ethnopharmacological relevance: Holothuria (Metriatyla) scabra Jaeger (H. scabra), sea cucumber, is the marine organism that has been used as traditional food and medicine to gain the health benefits since ancient time. Although our recent studies have shown that crude extracts from H. scabra exhibited neuroprotective effects against Parkinson's disease (PD), the underlying mechanisms and bioactive compounds are still unknown. Aim of the study: In the present study, we examined the efficacy of purified compounds from H. scabra and their underlying mechanism on α-synuclein degradation and neuroprotection against α-synuclein-mediated neurodegeneration in a transgenic Caenorhabditis elegans PD model. Material and methods: The H. scabra compounds (HSEA-P1 and P2) were purified and examined for their toxicity and optimal dose-range by food-clearance and lifespan assays. The α-synuclein degradation and neuroprotection against α-synuclein-mediated neurodegeneration were determined using transgenic C. elegans model, Punc-54::α-syn and Pdat-1:: α-syn; Pdat-1::GFP, respectively, and then further investigated by determining the behavioral assays including locomotion rate, basal slowing rate, ethanol avoidance, and area-restricted searching. The underlying mechanisms related to autophagy were clarified by quantitative PCR and RNAi experiments. Results: Our results showed that HSEA-P1 and HSEA-P2 significantly diminished α-synuclein accumulation, improved motility deficits, and recovered the shortened lifespan. Moreover, HSEA-P1 and HSEA-P2 significantly protected dopaminergic neurons from α-synuclein toxicity and alleviated dopamine-associated behavioral deficits, i.e., basal slowing, ethanol avoidance, and area-restricted searching. HSEA-P1 and HSEA-P2 also up-regulated autophagy-related genes, including beclin-1/bec-1, lc-3/lgg-1, and atg-7/atg-7. RNA interference (RNAi) of these genes in transgenic α-synuclein worms confirmed that lc-3/lgg-1 and atg-7/atg-7 were required for α-synuclein degradation and DAergic neuroprotection activities of HSEA-P1 and HSEA-P2. NMR and mass spectrometry analysis revealed that the HSEA-P1 and HSEA-P2 contained diterpene glycosides. Conclusion: These findings indicate that diterpene glycosides extracted from H. scabra decreases α-synuclein accumulation and protects α-synuclein-mediated DAergic neuronal loss and its toxicities via lgg-1 and atg-7.
AB - Ethnopharmacological relevance: Holothuria (Metriatyla) scabra Jaeger (H. scabra), sea cucumber, is the marine organism that has been used as traditional food and medicine to gain the health benefits since ancient time. Although our recent studies have shown that crude extracts from H. scabra exhibited neuroprotective effects against Parkinson's disease (PD), the underlying mechanisms and bioactive compounds are still unknown. Aim of the study: In the present study, we examined the efficacy of purified compounds from H. scabra and their underlying mechanism on α-synuclein degradation and neuroprotection against α-synuclein-mediated neurodegeneration in a transgenic Caenorhabditis elegans PD model. Material and methods: The H. scabra compounds (HSEA-P1 and P2) were purified and examined for their toxicity and optimal dose-range by food-clearance and lifespan assays. The α-synuclein degradation and neuroprotection against α-synuclein-mediated neurodegeneration were determined using transgenic C. elegans model, Punc-54::α-syn and Pdat-1:: α-syn; Pdat-1::GFP, respectively, and then further investigated by determining the behavioral assays including locomotion rate, basal slowing rate, ethanol avoidance, and area-restricted searching. The underlying mechanisms related to autophagy were clarified by quantitative PCR and RNAi experiments. Results: Our results showed that HSEA-P1 and HSEA-P2 significantly diminished α-synuclein accumulation, improved motility deficits, and recovered the shortened lifespan. Moreover, HSEA-P1 and HSEA-P2 significantly protected dopaminergic neurons from α-synuclein toxicity and alleviated dopamine-associated behavioral deficits, i.e., basal slowing, ethanol avoidance, and area-restricted searching. HSEA-P1 and HSEA-P2 also up-regulated autophagy-related genes, including beclin-1/bec-1, lc-3/lgg-1, and atg-7/atg-7. RNA interference (RNAi) of these genes in transgenic α-synuclein worms confirmed that lc-3/lgg-1 and atg-7/atg-7 were required for α-synuclein degradation and DAergic neuroprotection activities of HSEA-P1 and HSEA-P2. NMR and mass spectrometry analysis revealed that the HSEA-P1 and HSEA-P2 contained diterpene glycosides. Conclusion: These findings indicate that diterpene glycosides extracted from H. scabra decreases α-synuclein accumulation and protects α-synuclein-mediated DAergic neuronal loss and its toxicities via lgg-1 and atg-7.
KW - Caenorhabditis elegans
KW - Diterpene glycoside
KW - Dopaminergic neuron
KW - Holothuria scabra
KW - Parkinson's disease
KW - α-synuclein
UR - http://www.scopus.com/inward/record.url?scp=85108378544&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85108378544&partnerID=8YFLogxK
U2 - 10.1016/j.jep.2021.114347
DO - 10.1016/j.jep.2021.114347
M3 - Article
C2 - 34147616
AN - SCOPUS:85108378544
SN - 0378-8741
VL - 279
JO - Journal of Ethnopharmacology
JF - Journal of Ethnopharmacology
M1 - 114347
ER -